cisapride has been researched along with Infant, Premature, Diseases in 21 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Infant, Premature, Diseases: Diseases that occur in PREMATURE INFANTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gastrointestinal prokinetic agents, such as cisapride, are commonly used in pediatric practice to improve gastric emptying, to decrease emesis, to improve lower esophageal sphincter tone, and to improve irritability and feeding aversion associated with gastroesophageal reflux (GER)." | 9.09 | Cisapride decreases gastroesophageal reflux in preterm infants. ( Ariagno, RL; Baldwin, RB; Conrad, C; Kikkert, MA; Mirmiran, M, 2001) |
| " In conclusion, cisapride has a positive influence on GOR parameters during caffeine treatment without impairing the oral bioavailability or therapeutic effect of caffeine." | 5.31 | Effect of cisapride on acid gastro-oesophageal reflux during treatment with caffeine. ( Baisch, HJ; Heimann, G; Kentrup, H; Kusenbach, G; Skopnik, H, 2000) |
| "Gastroesophageal reflux (GER) is very common in infants, especially in prematures and may be cause of gastrointestinal and cardiorespiratory symptoms." | 5.31 | [QTc interval in newborns with gastroesophageal reflux treated with cisapride and ranitidine]. ( Colli, A; Compagnoni, G; Introvini, P; Lista, G; Maestri, L; Massari, D; Menchini, M; Meroni, M; Porcelli, F, 2000) |
| "To evaluate whether prophylactic use of cisapride will reduce the incidence of feed intolerance and gastro-esophageal reflux, and improve gastric emptying in early neonatal period in preterm babies." | 5.09 | A double-blind placebo-controlled study on prophylactic use of cisapride on feed intolerance and gastric emptying in preterm neonates. ( Bal, CS; Deorari, AK; Paul, VK; Reddy, PS; Singh, M, 2000) |
| "Gastrointestinal prokinetic agents, such as cisapride, are commonly used in pediatric practice to improve gastric emptying, to decrease emesis, to improve lower esophageal sphincter tone, and to improve irritability and feeding aversion associated with gastroesophageal reflux (GER)." | 5.09 | Cisapride decreases gastroesophageal reflux in preterm infants. ( Ariagno, RL; Baldwin, RB; Conrad, C; Kikkert, MA; Mirmiran, M, 2001) |
| "During childhood, gastroparesis is quite rare, and is mostly seen in preterm infants, with either immaturity of the gastrointestinal tract, or when allergic to cow's milk protein." | 2.42 | Current pharmacological treatment of gastroparesis. ( Hauser, B; Salvatore, S; Vandenplas, Y, 2004) |
| " In conclusion, cisapride has a positive influence on GOR parameters during caffeine treatment without impairing the oral bioavailability or therapeutic effect of caffeine." | 1.31 | Effect of cisapride on acid gastro-oesophageal reflux during treatment with caffeine. ( Baisch, HJ; Heimann, G; Kentrup, H; Kusenbach, G; Skopnik, H, 2000) |
| "Gastroesophageal reflux (GER) is very common in infants, especially in prematures and may be cause of gastrointestinal and cardiorespiratory symptoms." | 1.31 | [QTc interval in newborns with gastroesophageal reflux treated with cisapride and ranitidine]. ( Colli, A; Compagnoni, G; Introvini, P; Lista, G; Maestri, L; Massari, D; Menchini, M; Meroni, M; Porcelli, F, 2000) |
| "Cisapride treatment of premature infants of <36 weeks' gestation and <3 months of age in NICUs appears to be widespread in the United States." | 1.30 | Cisapride: a survey of the frequency of use and adverse events in premature newborns. ( Lemons, JA; Molteni, RA; Ward, RM, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (47.62) | 18.2507 |
| 2000's | 10 (47.62) | 29.6817 |
| 2010's | 1 (4.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caraballo, L | 1 |
| Molina, G | 1 |
| Weitz, D | 1 |
| Piskulic, L | 1 |
| Avila, A | 1 |
| Marzi, M | 1 |
| Vandenplas, Y | 2 |
| Hauser, B | 1 |
| Salvatore, S | 1 |
| Kohl, M | 1 |
| Wuerdemann, I | 1 |
| Clemen, J | 1 |
| Iven, H | 1 |
| Katalinic, A | 1 |
| Moeller, JC | 1 |
| Craig, JS | 2 |
| Bedu, A | 1 |
| Lupoglazoff, JM | 1 |
| Faure, C | 1 |
| Denjoy, I | 1 |
| Casasoprana, A | 1 |
| Aujard, Y | 1 |
| Premji, SS | 1 |
| Wilson, J | 1 |
| Paes, B | 1 |
| Gray, S | 1 |
| Bernardini, S | 1 |
| Semama, DS | 1 |
| Huet, F | 1 |
| Sgro, C | 1 |
| Gouyon, JB | 1 |
| Ward, RM | 1 |
| Lemons, JA | 1 |
| Molteni, RA | 1 |
| Lander, A | 1 |
| Desai, A | 1 |
| McClure, RJ | 1 |
| Kristensen, JH | 1 |
| Grauaug, A | 1 |
| Mukhopadhyay, K | 1 |
| Narang, A | 1 |
| Kumar, P | 1 |
| Chakraborty, S | 1 |
| Mittal, BR | 1 |
| Cairns, P | 1 |
| Kentrup, H | 1 |
| Baisch, HJ | 1 |
| Kusenbach, G | 1 |
| Heimann, G | 1 |
| Skopnik, H | 1 |
| McClure, BG | 1 |
| Tubman, TR | 1 |
| Reddy, PS | 1 |
| Deorari, AK | 1 |
| Bal, CS | 1 |
| Paul, VK | 1 |
| Singh, M | 1 |
| Ariagno, RL | 1 |
| Kikkert, MA | 1 |
| Mirmiran, M | 1 |
| Conrad, C | 1 |
| Baldwin, RB | 1 |
| Lista, G | 1 |
| Maestri, L | 1 |
| Meroni, M | 1 |
| Massari, D | 1 |
| Colli, A | 1 |
| Porcelli, F | 1 |
| Menchini, M | 1 |
| Introvini, P | 1 |
| Compagnoni, G | 1 |
| Basu, S | 1 |
| Bishnoi, DS | 1 |
| Barnett, CP | 1 |
| Omari, T | 1 |
| Davidson, GP | 1 |
| Goodchild, L | 1 |
| Lontis, R | 1 |
| Dent, J | 1 |
| Haslam, RR | 1 |
| Vanderwinden, JM | 1 |
| Dassonville, M | 1 |
| Van der Veken, E | 1 |
| Cadranel, S | 1 |
| De Laet, MH | 1 |
3 reviews available for cisapride and Infant, Premature, Diseases
| Article | Year |
|---|---|
[Proarrhythmic effects of domperidone in infants: a systematic review].
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Cisapride; Contraindications; Cytochrome P-450 CYP3A; Dom | 2014 |
Current pharmacological treatment of gastroparesis.
Topics: Adult; Child; Cisapride; Domperidone; Erythromycin; Gastrointestinal Agents; Gastroparesis; Humans; | 2004 |
Cisapride: a review of the evidence supporting its use in premature infants with feeding intolerance.
Topics: Cisapride; Feeding and Eating Disorders of Childhood; Gastrointestinal Motility; Humans; Infant Nutr | 1997 |
6 trials available for cisapride and Infant, Premature, Diseases
| Article | Year |
|---|---|
Cisapride may improve feeding tolerance of preterm infants: a randomized placebo-controlled trial.
Topics: Birth Weight; Cisapride; Digestive System Diseases; Electrocardiography; Enteral Nutrition; Female; | 2005 |
Effects of cisapride on QTc interval in neonates.
Topics: Cisapride; Electrocardiography; Gastroesophageal Reflux; Gestational Age; Humans; Infant, Newborn; I | 1997 |
Randomised controlled trial of cisapride in preterm infants.
Topics: Cisapride; Contraindications; Cross-Over Studies; Double-Blind Method; Gastric Emptying; Gastroesoph | 1999 |
A double-blind placebo-controlled study on prophylactic use of cisapride on feed intolerance and gastric emptying in preterm neonates.
Topics: Cisapride; Double-Blind Method; Food Hypersensitivity; Gastric Emptying; Gastroesophageal Reflux; Ga | 2000 |
Cisapride decreases gastroesophageal reflux in preterm infants.
Topics: Cisapride; Comorbidity; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gast | 2001 |
Effect of cisapride on gastric emptying in premature infants with feed intolerance.
Topics: Breath Tests; Cisapride; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration S | 2001 |
12 other studies available for cisapride and Infant, Premature, Diseases
| Article | Year |
|---|---|
Cisapride and intestinal dysmotility: the final word?
Topics: Arrhythmias, Cardiac; Cisapride; Digestive System Diseases; Gastrointestinal Agents; Gastrointestina | 2005 |
Cisapride high dosage and long QT interval.
Topics: Cisapride; Gastroesophageal Reflux; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Prem | 1997 |
Cisapride: a survey of the frequency of use and adverse events in premature newborns.
Topics: Cisapride; Gastrointestinal Agents; Health Care Surveys; Humans; Infant, Newborn; Infant, Premature; | 1999 |
The risks and benefits of cisapride in premature neonates, infants, and children.
Topics: Age Factors; Child; Child, Preschool; Cisapride; Contraindications; Gastrointestinal Agents; Gastroi | 1998 |
Gastroesophageal reflux and pulmonary complication in a neonate.
Topics: Antiemetics; Apnea; Cisapride; Follow-Up Studies; Gastroesophageal Reflux; Gastrointestinal Agents; | 1998 |
The risks and benefits of cisapride.
Topics: Cisapride; Gastrointestinal Agents; Gastrointestinal Diseases; Humans; Infant, Newborn; Infant, Prem | 1999 |
Effect of cisapride on acid gastro-oesophageal reflux during treatment with caffeine.
Topics: Caffeine; Cisapride; Gastroesophageal Reflux; Gastrointestinal Agents; Humans; Hydrogen-Ion Concentr | 2000 |
Role of cisapride in preterm infants.
Topics: Cisapride; Contraindications; Electrocardiography; Gastroesophageal Reflux; Gastrointestinal Agents; | 1999 |
Randomised controlled trial of cisapride in preterm infants.
Topics: Cisapride; Gastroesophageal Reflux; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Infa | 2000 |
[QTc interval in newborns with gastroesophageal reflux treated with cisapride and ranitidine].
Topics: Cisapride; Electrocardiography; Gastroesophageal Reflux; Gastrointestinal Agents; Humans; Infant, Ne | 2000 |
Cisapride use in preterms.
Topics: Cisapride; Food Hypersensitivity; Gastric Emptying; Gastrointestinal Agents; Humans; Infant, Newborn | 2001 |
Post-necrotising enterocolitis pseudo-obstruction treated with Cisapride.
Topics: Cisapride; Colonic Pseudo-Obstruction; Enteral Nutrition; Enterocolitis, Pseudomembranous; Follow-Up | 1990 |